Literature DB >> 24789589

Heart failure in African Americans: disparities can be overcome.

Alok Sharma1, Monica Colvin-Adams, Clyde W Yancy.   

Abstract

African Americans are disproportionately affected by heart failure, with a high prevalence at an early age. Hypertension, diabetes, obesity, and chronic kidney disease are all common in African Americans and all predispose to heart failure. Neurohormonal imbalances, endothelial dysfunction, genetic polymorphisms, and socioeconomic factors also contribute. In general, the same evidence-based treatment guidelines that apply to white patients with heart failure also apply to African Americans. However, the combination of hydralazine and isosorbide dinitrate is advised specifically for African Americans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789589     DOI: 10.3949/ccjm.81a.13045

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  21 in total

1.  Estimated Glomerular Filtration Rate and 6-Minute Walk Distance in African Americans with Mild to Moderate Heart Failure.

Authors:  Karen M Vuckovic; Houry Puzantian
Journal:  Cardiorenal Med       Date:  2017-05-24       Impact factor: 2.041

2.  Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry.

Authors:  Tiffany M Powell-Wiley; Julius Ngwa; Selomie Kebede; Di Lu; Phillip J Schulte; Deepak L Bhatt; Clyde Yancy; Gregg C Fonarow; Michelle A Albert
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

3.  The effect of nurse-led group discussions by race on depressive symptoms in patients with heart failure.

Authors:  Ubolrat Piamjariyakul; Noreen C Thompson; Christy Russell; Carol E Smith
Journal:  Heart Lung       Date:  2018-03-30       Impact factor: 2.210

4.  Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study.

Authors:  Laura C Pinheiro; Evgeniya Reshetnyak; Madeline R Sterling; Emily B Levitan; Monika M Safford; Parag Goyal
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-07-24

5.  Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.

Authors:  Faraz S Ahmad; Hongyan Ning; Jonathan D Rich; Clyde W Yancy; Donald M Lloyd-Jones; John T Wilkins
Journal:  JACC Heart Fail       Date:  2016-10-12       Impact factor: 12.035

6.  Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.

Authors:  David E Lanfear; Joseph J Gibbs; Jia Li; Ruicong She; Christopher Petucci; Jeffrey A Culver; W H Wilson Tang; Yigal M Pinto; L Keoki Williams; Hani N Sabbah; Stephen J Gardell
Journal:  JACC Heart Fail       Date:  2017-11       Impact factor: 12.035

7.  Anger, hostility, and hospitalizations in patients with heart failure.

Authors:  Felicia Keith; David S Krantz; Rusan Chen; Kristie M Harris; Catherine M Ware; Amy K Lee; Paula G Bellini; Stephen S Gottlieb
Journal:  Health Psychol       Date:  2017-06-26       Impact factor: 4.267

Review 8.  Genetics of Obesity in Diverse Populations.

Authors:  Kristin L Young; Mariaelisa Graff; Lindsay Fernandez-Rhodes; Kari E North
Journal:  Curr Diab Rep       Date:  2018-11-19       Impact factor: 4.810

9.  Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction.

Authors:  Boback Ziaeian; Paul A Heidenreich; Haolin Xu; Adam D DeVore; Roland A Matsouaka; Adrian F Hernandez; Deepak L Bhatt; Clyde W Yancy; Gregg C Fonarow
Journal:  JACC Heart Fail       Date:  2018-04-11       Impact factor: 12.035

10.  Survival Association of Angiotensin Inhibitors in Heart Failure With Reduced Ejection Fraction: Comparisons Using Self-Identified Race and Genomic Ancestry.

Authors:  Jasmine A Luzum; Ozioma Edokobi; Michael P Dorsch; Edward Peterson; Bin Liu; Hongsheng Gui; L Keoki Williams; David E Lanfear
Journal:  J Card Fail       Date:  2021-08-21       Impact factor: 6.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.